Skip to main content
Top
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

Reasons for implementation success despite health system constraints: qualitative insights on ‘what worked’ for cotrimoxazole preventive therapy

Authors: Pia Müller, Edna Mabasso, Luís Velez Lapão, Mohsin Sidat

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Although Cotrimoxazole preventive therapy (CPT) has shown to be highly efficacious in reducing morbidity and mortality among people living with Human immunodeficiency virus (HIV) under ‘ideal world’ study conditions, operational challenges are limiting its effectiveness when implementing in countries most affected by the HIV epidemic. The fact that Mozambican authorities reported high coverage of CPT among patients with HIV, has led to this qualitative case study aimed at exploring possible factors responsible for the successful implementation of CPT in the Province of Maputo.

Methods

Between February and April 2019, we individually interviewed nine governmental stakeholders, including the person responsible for the HIV Program, the person responsible for the TB Program and the person responsible for Pharmaceutical management at three administrative levels (central, provincial and district level). Interviews were recorded, transcribed, and analysed thematically using MAXQDA Analytics Pro. Findings were translated from Portuguese into English.

Results

Five themes iteratively emerged: (a) Role of governance & leadership, (b) Pharmaceutical strategies, (c) Service delivery modifications, (d) Health care provider factors, and (e) Patients’ perspectives.
Interviews revealed that continuous supply of cotrimoxazole (CTZ) had been facilitated through multiple-source procurement and a push-pull strategy. One part of CTZ arrived in kits that were imported from overseas and distributed to public health facilities based on their number of outpatient consultations (push strategy). Another part of CTZ was locally produced and distributed as per health facility demand (pull strategy). Strong district level accountability also contributed to the public availability of CTZ. Interviewees praised models of differentiated care, the integrated HIV service delivery and drug delivery strategies for reducing long queues at the health facility, better accommodating patients’ needs and reducing their financial and organisational burden.

Conclusions

This study presents aspects that governmental experts believed to be key for the implementation of CPT in the Province of Maputo, Mozambique. Enhancing the implementation outcomes – drug availability and feasibility of the health facility-based service delivery – seemed crucial for the implementation progress. Reasons for the remarkable patient acceptability of CPT in our study setting should be further investigated.
Appendix
Available only for authorised users
Footnotes
1
The “Program for sexually transmitted infections, HIV/AIDS”, is referred to as “HIV Program”.
 
2
A technical working group is a multidisciplinary group of experts who work together on specific goals. Technical working group meetings allow stakeholders to discuss the state of research on a topic, the progress in policy development and implementation of a specific intervention.
 
3
Via clássica’ is the local term for drugs distributed through the pull-system. In other words, drugs that arrive at the health facility ‘via clássica’ have been ordered by authorized health facility personnel. Ordering drugs is reserved for larger health facilities that fulfil certain requirements, e.g. employment of at least one medical doctor).
 
Literature
1.
go back to reference Kagaayi J, Serwadda D. The history of the HIV/AIDS epidemic in Africa. Curr HIV/AIDS Rep. 2016;13(4):187–93.CrossRefPubMed Kagaayi J, Serwadda D. The history of the HIV/AIDS epidemic in Africa. Curr HIV/AIDS Rep. 2016;13(4):187–93.CrossRefPubMed
2.
go back to reference Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N’Dri-Yoman T, Salamon R. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial Cotrimo-CI. Study Group. Lancet (London, England). 1999;353(9163):1463–8.CrossRefPubMed Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N’Dri-Yoman T, Salamon R. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial Cotrimo-CI. Study Group. Lancet (London, England). 1999;353(9163):1463–8.CrossRefPubMed
3.
go back to reference Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d’Ivoire: a randomised controlled trial. Lancet (London, England). 1999;353(9163):1469–75.CrossRefPubMed Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d’Ivoire: a randomised controlled trial. Lancet (London, England). 1999;353(9163):1469–75.CrossRefPubMed
4.
go back to reference World Health Organization. Provisional WHO/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci. 2000;1(1):30–1. World Health Organization. Provisional WHO/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci. 2000;1(1):30–1.
5.
go back to reference World Health Organization: Chapter 6: General Care and Managing common Coinfections and Comorbidities. In: Consolidated Guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach (2021): pp. 234–245. https://www.who.int/publications/i/item/9789240031593. Accessed 11th of Aug 2022. World Health Organization: Chapter 6: General Care and Managing common Coinfections and Comorbidities. In: Consolidated Guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach (2021): pp. 234–245. https://​www.​who.​int/​publications/​i/​item/​9789240031593. Accessed 11th of Aug 2022.
6.
go back to reference Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, Kaplan JE, Doherty MC. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis. Lancet HIV. 2015;2(4):e137–50.CrossRefPubMed Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, Kaplan JE, Doherty MC. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis. Lancet HIV. 2015;2(4):e137–50.CrossRefPubMed
7.
go back to reference Anywaine Z, Levin J, Kasirye R, Lutaakome JK, Abaasa A, Nunn A, Grosskurth H, Munderi P. Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): a randomised placebo controlled trial. PLoS One. 2018;13(12):e0206907.CrossRefPubMedPubMedCentral Anywaine Z, Levin J, Kasirye R, Lutaakome JK, Abaasa A, Nunn A, Grosskurth H, Munderi P. Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): a randomised placebo controlled trial. PLoS One. 2018;13(12):e0206907.CrossRefPubMedPubMedCentral
8.
go back to reference Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis. 2015;15(3):327–39.CrossRefPubMed Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis. 2015;15(3):327–39.CrossRefPubMed
9.
go back to reference Batra P, Deo V, Mathur P, Gupta AK. Cotrimoxazole, a wonder drug in the era of multiresistance: case report and review of literature. J Lab Physicians. 2017;9(3):210–3.CrossRefPubMedPubMedCentral Batra P, Deo V, Mathur P, Gupta AK. Cotrimoxazole, a wonder drug in the era of multiresistance: case report and review of literature. J Lab Physicians. 2017;9(3):210–3.CrossRefPubMedPubMedCentral
10.
go back to reference Hutchinson E, Parkhurst J, Phiri S, Gibb DM, Chishinga N, Droti B, Hoskins S. National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links. BMC Health Res Policy Syst. 2011;9 Suppl 1(Suppl 1):S6.CrossRef Hutchinson E, Parkhurst J, Phiri S, Gibb DM, Chishinga N, Droti B, Hoskins S. National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links. BMC Health Res Policy Syst. 2011;9 Suppl 1(Suppl 1):S6.CrossRef
11.
go back to reference Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, Parkhurst J. Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy. Bull World Health Organ. 2011;89(4):312–6.CrossRefPubMedPubMedCentral Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, Parkhurst J. Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy. Bull World Health Organ. 2011;89(4):312–6.CrossRefPubMedPubMedCentral
12.
go back to reference Müller P, Velez Lapão L. Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid—Preventive therapies for people living with HIV. PLoS One. 2022;17(3):e0251612.CrossRefPubMedPubMedCentral Müller P, Velez Lapão L. Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid—Preventive therapies for people living with HIV. PLoS One. 2022;17(3):e0251612.CrossRefPubMedPubMedCentral
13.
go back to reference Chan AK, Ford D, Namata H, Muzambi M, Nkhata MJ, Abongomera G, Mambule I, South A, Revill P, Grundy C, et al. The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res. 2014;14:352.CrossRefPubMedPubMedCentral Chan AK, Ford D, Namata H, Muzambi M, Nkhata MJ, Abongomera G, Mambule I, South A, Revill P, Grundy C, et al. The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res. 2014;14:352.CrossRefPubMedPubMedCentral
14.
go back to reference Horwood C, Haskins L, Vermaak K, Phakathi S, Subbaye R, Doherty T. Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women’s health services. Trop Med Int Health. 2010;15(9):992–9.PubMed Horwood C, Haskins L, Vermaak K, Phakathi S, Subbaye R, Doherty T. Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women’s health services. Trop Med Int Health. 2010;15(9):992–9.PubMed
15.
go back to reference Kamuhabwa AA, Gordian R, Mutagonda RF. Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania. Drug Healthc Patient Saf. 2016;8:91–100.CrossRefPubMedPubMedCentral Kamuhabwa AA, Gordian R, Mutagonda RF. Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania. Drug Healthc Patient Saf. 2016;8:91–100.CrossRefPubMedPubMedCentral
16.
go back to reference Kamuhabwa AAR, Manyanga V. Challenges facing effective implementation of cotrimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities. Drug Healthc Patient Saf. 2015;7:147–56.CrossRefPubMedPubMedCentral Kamuhabwa AAR, Manyanga V. Challenges facing effective implementation of cotrimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities. Drug Healthc Patient Saf. 2015;7:147–56.CrossRefPubMedPubMedCentral
17.
go back to reference Louwagie G, Girdler-Brown B, Odendaal R, Rossouw T, Johnson S, Van der Walt M. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care. Int J Tuberc Lung Dis. 2012;16(8):1052–8.CrossRefPubMed Louwagie G, Girdler-Brown B, Odendaal R, Rossouw T, Johnson S, Van der Walt M. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care. Int J Tuberc Lung Dis. 2012;16(8):1052–8.CrossRefPubMed
18.
go back to reference Mugomeri E, Olivier D, Van Den Heever WM. Health system challenges affecting the implementation of isoniazid preventive therapy in people living with HIV in Lesotho. HIV AIDS Rev. 2018;17(4):299–307.CrossRef Mugomeri E, Olivier D, Van Den Heever WM. Health system challenges affecting the implementation of isoniazid preventive therapy in people living with HIV in Lesotho. HIV AIDS Rev. 2018;17(4):299–307.CrossRef
20.
go back to reference Naikoba S, Senjovu KD, Mugabe P, McCarthy CF, Riley PL, Kadengye DT, Dalal S. Improved HIV and TB knowledge and competence among mid-level providers in a cluster-randomized trial of One-on-One mentorship for task shifting. J Acquir Immune Defic Syndr. 2017;75(5):e120–7.CrossRefPubMed Naikoba S, Senjovu KD, Mugabe P, McCarthy CF, Riley PL, Kadengye DT, Dalal S. Improved HIV and TB knowledge and competence among mid-level providers in a cluster-randomized trial of One-on-One mentorship for task shifting. J Acquir Immune Defic Syndr. 2017;75(5):e120–7.CrossRefPubMed
21.
go back to reference Okot-Chono R, Mugisha F, Adatu F, Madraa E, Dlodlo R, Fujiwara P. Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda. Int J Tuberc Lung Dis. 2009;13(8):955–61.PubMed Okot-Chono R, Mugisha F, Adatu F, Madraa E, Dlodlo R, Fujiwara P. Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda. Int J Tuberc Lung Dis. 2009;13(8):955–61.PubMed
22.
go back to reference Okwera A, Mafigiri DK, Guwatudde D, Whalen C, Joloba M. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis. Afr Health Sci. 2015;15(1):49–57.CrossRefPubMedPubMedCentral Okwera A, Mafigiri DK, Guwatudde D, Whalen C, Joloba M. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis. Afr Health Sci. 2015;15(1):49–57.CrossRefPubMedPubMedCentral
23.
go back to reference Sibanda EL, Bernays S, Weller IV, Hakim JG, Cowan FM. Manuscript title: facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare Zimbabwe. BMC Public Health. 2015;15:784.CrossRefPubMedPubMedCentral Sibanda EL, Bernays S, Weller IV, Hakim JG, Cowan FM. Manuscript title: facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare Zimbabwe. BMC Public Health. 2015;15:784.CrossRefPubMedPubMedCentral
25.
go back to reference Haakenstad A, Irvine CMS, Knight M, Bintz C, Aravkin AY, Zheng P, Gupta V, Abrigo MRM, Abushouk AI, Adebayo OM, et al. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;399(10341):2129–54.CrossRef Haakenstad A, Irvine CMS, Knight M, Bintz C, Aravkin AY, Zheng P, Gupta V, Abrigo MRM, Abushouk AI, Adebayo OM, et al. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;399(10341):2129–54.CrossRef
29.
go back to reference Creswell JW, Creswell JD. Research design: qualitative, quantitative, and mixed methods approaches, 4th edn. Los Angeles: Sage publications; 2014. Creswell JW, Creswell JD. Research design: qualitative, quantitative, and mixed methods approaches, 4th edn. Los Angeles: Sage publications; 2014.
32.
go back to reference Velardo S, Elliott S. Co-interviewing in qualitative social research: prospects, merits and considerations. Int J Qual Methods. 2021;20:16094069211054920.CrossRef Velardo S, Elliott S. Co-interviewing in qualitative social research: prospects, merits and considerations. Int J Qual Methods. 2021;20:16094069211054920.CrossRef
33.
go back to reference Flick U. The SAGE handbook of qualitative data analysis. Los Angeles: Sage; 2014. Flick U. The SAGE handbook of qualitative data analysis. Los Angeles: Sage; 2014.
34.
go back to reference Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1(3):385–405.CrossRef Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1(3):385–405.CrossRef
35.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRefPubMed Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRefPubMed
36.
go back to reference Instituto Nacional de Estatística MdS, Ministério do Plano e Finanças, Centro de Estudos de População-UEM, Conselho Nacional de Combate ao, HIV/SIDA, Faculdade de Medicina-UEM, Ministério da Educação.: Demographic impact of HIV/AIDS in Mozambique (Update 2000). 2002. Instituto Nacional de Estatística MdS, Ministério do Plano e Finanças, Centro de Estudos de População-UEM, Conselho Nacional de Combate ao, HIV/SIDA, Faculdade de Medicina-UEM, Ministério da Educação.: Demographic impact of HIV/AIDS in Mozambique (Update 2000). 2002.
38.
go back to reference Dias V, Henry D, Searles A. MDS-3: Managing access to medicines and health technologies. In: 26 Kit System Management. 2012. Dias V, Henry D, Searles A. MDS-3: Managing access to medicines and health technologies. In: 26 Kit System Management. 2012.
39.
go back to reference Betrán AP, Bergel E, Griffin S, Melo A, Nguyen MH, Carbonell A, Mondlane S, Merialdi M, Temmerman M, Gülmezoglu AM. Provision of medical supply kits to improve quality of antenatal care in Mozambique: a stepped-wedge cluster randomised trial. Lancet Glob Health. 2018;6(1):e57–65.CrossRefPubMed Betrán AP, Bergel E, Griffin S, Melo A, Nguyen MH, Carbonell A, Mondlane S, Merialdi M, Temmerman M, Gülmezoglu AM. Provision of medical supply kits to improve quality of antenatal care in Mozambique: a stepped-wedge cluster randomised trial. Lancet Glob Health. 2018;6(1):e57–65.CrossRefPubMed
40.
go back to reference Bossert TJ, Bowser DM, Amenyah JK. Is decentralization good for logistics systems? Evidence on essential medicine logistics in Ghana and Guatemala. Health Policy Plan. 2007;22(2):73–82.CrossRefPubMed Bossert TJ, Bowser DM, Amenyah JK. Is decentralization good for logistics systems? Evidence on essential medicine logistics in Ghana and Guatemala. Health Policy Plan. 2007;22(2):73–82.CrossRefPubMed
Metadata
Title
Reasons for implementation success despite health system constraints: qualitative insights on ‘what worked’ for cotrimoxazole preventive therapy
Authors
Pia Müller
Edna Mabasso
Luís Velez Lapão
Mohsin Sidat
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-10631-x

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue